Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Lunn

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
JRSM Open|September 12, 2018
Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experienceJ A Kinsella, S R Irani, R Hollingsworth, et al.
European Journal of Neurology|July 24, 2018
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatmentS Keddie, S J Crisp, J Blackaby, et al.
Neuromuscular Disorders : NMD|April 3, 2012
Hand weakness in Charcot-Marie-Tooth disease 1XP J Arthur-Farraj, S M Murphy, M Laura, et al.
Journal of Neurochemistry|June 15, 2000
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalizationM P Lunn, L A Johnson, S E Fromholt, et al.
Annals of Clinical and Translational Neurology|July 23, 2025
Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic FailureS Koay, E Vichayanrat, F Bremner, et al.
Journal of the Neurological Sciences|November 3, 2019
Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?R Keh, A Kahlil, L Nihoyannopoulos, et al.
Journal of the Neurological Sciences|July 20, 2020
Corrigendum to Routine blood monitoring in maintenance Immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant? [Journal of the Neurological Sciences 408 (2020) 116527]R Keh, A Khalil, L Nihoyannopoulos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2009
GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatmentA W Michell, M Laura, J Blake, et al.
Journal of Neurology|August 4, 2016
Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndromeL Schirmer, V Worthington, U Solloch, et al.
Trials|February 20, 2021
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)S R M Bus, L Zambreanu, A Abbas, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
JRSM Open|September 12, 2018
Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experienceJ A Kinsella, S R Irani, R Hollingsworth, et al.
European Journal of Neurology|July 24, 2018
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatmentS Keddie, S J Crisp, J Blackaby, et al.
Neuromuscular Disorders : NMD|April 3, 2012
Hand weakness in Charcot-Marie-Tooth disease 1XP J Arthur-Farraj, S M Murphy, M Laura, et al.
Journal of Neurochemistry|June 15, 2000
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalizationM P Lunn, L A Johnson, S E Fromholt, et al.
Annals of Clinical and Translational Neurology|July 23, 2025
Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic FailureS Koay, E Vichayanrat, F Bremner, et al.
Journal of the Neurological Sciences|November 3, 2019
Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?R Keh, A Kahlil, L Nihoyannopoulos, et al.
Journal of the Neurological Sciences|July 20, 2020
Corrigendum to Routine blood monitoring in maintenance Immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant? [Journal of the Neurological Sciences 408 (2020) 116527]R Keh, A Khalil, L Nihoyannopoulos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2009
GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatmentA W Michell, M Laura, J Blake, et al.
Journal of Neurology|August 4, 2016
Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndromeL Schirmer, V Worthington, U Solloch, et al.
Trials|February 20, 2021
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)S R M Bus, L Zambreanu, A Abbas, et al.
Pageof 3